| Ytd | -51.25% | |
| 1y | -61.46% |
| Open | 4.85 | Prev Close | 4.85 | Low | 4.62 | High | 4.81 | Mkt Cap | 228.29M |
| Vol | 842.64K | Avg Vol | 678.48K | EPS | -4.38 | P/E | N/A | Forward P/E | 6.47 |
| Beta | 1.13 | Short Ratio | 1.83 | Inst. Own | 81.02% | Dividend | 0.24 | Div Yield | 3.64 |
| Ex Div Date | 11-29 | Earning | 11-05 | 50-d Avg | 5.07 | 200-d Avg | 7.52 | 1yr Est | 6.92 |
NUS News
STM and NUS launch a four-year lab to advance low-power edge AI for robots, humanoids and drones usi
STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore HELIX jo
Dallas, Texas--(Newsfile Corp. - August 11, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate
NUS' second-quarter revenues fall 17.1% and EPS drops 53.5%, while it cuts the 2026 revenue and adju
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earning
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.2 per share, in line with the Zacks
Nu Skin Enterprises (NYSE:NUS) is looking for FY2026 Adj EPS of $0.70-$0.90 vs $1.00 analyst estimat
Nu Skin Enterprises (NYSE:NUS) is looking for Q3 Adj EPS of $0.10-$0.20 vs $0.32 analyst estimate. s
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.20 per share which met the analyst
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter re
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of dir
Nu Skin Enterprises (NYSE: NUS - Get Free Report) and BioHarvest Sciences (NASDAQ: BHST - Get Free R
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release
July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Invers
Russell 2000 & 3000 Maybe Hold Forever Stocks (MHFS) featured high (>4%) dividends, attractive or ne
5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics
Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited rec
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies fo
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The late
EL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backe
The June GVAS portfolio highlights 13 'safer,' fair-priced large-cap value stocks with strong divide
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Nu Skin Enterprises (NYSE:NUS) lowers FY2026 GAAP EPS guidance from $0.80-$1.20 to $0.70-$1.10 vs $1
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.15-$0.25 vs $0.23 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.14 per share which missed the analy
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Ch
Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operati
Nu Skin Enterprises Inc (NYSE: NUS) reported Q4 2025 results that missed expectations, with EPS of 2
Nu Skin Enterprises (NYSE:NUS) sees FY2026 sales of $1.350 billion-$1.500 billion vs $1.530 billion
Nu Skin Enterprises (NYSE:NUS) sees Q1 sales of $320.000 million-$340.000 million vs $356.800 millio
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.29 per share which missed the analy
Investors should avoid speculative assets and risky stocks in volatile markets. Safe-haven options l
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $3.05-$3.25 to $3.15-$3.25 vs $3
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $1.15-$1.35 to $1.25-$1.35 vs $1.
Nu Skin Enterprises (NYSE:NUS) is looking for Q4 GAAP EPS of $0.25-$0.35 vs $0.33 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.34 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.43 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) is looking for Q3 GAAP EPS of $0.25-$0.35 vs $0.29 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $2.80-$3.20 to $3.05-$3.20 vs $0
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $0.90-$1.30 to $1.15-$1.35 vs $0.
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.20-$0.30 vs $0.24 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) affirms FY2025 Adj EPS guidance from $0.90-$1.30 to $0.90-$1.30 vs $0
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.23 per share which beat the analyst